Rationale for phosphodiesterase-4 inhibition as a treatment strategy for interstitial lung diseases associated with rheumatic diseases

By sjmartinez • December 25, 2024

Aringer M, Distler O, Hoffmann-Vold AM, Kuwana M, Prosch H, Volkmann ER. Rationale for phosphodiesterase-4 inhibition as a treatment strategy for interstitial lung diseases associated with rheumatic diseases. RMD Open. 2024 Dec 23;10(4):e004704. doi: 10.1136/rmdopen-2024-004704. PMID: 39719300.

Tags: Autoimmune Diseases, Publications, Pulmonary fibrosis, Rheumatology, Therapeutics

Brief Report: Association of HIV and HCV With Adverse Coronary Artery Phenotypes in Women: Findings From a Cross-Sectional Study

Shitole SG, Chen E, Naveed M, Xue X, Sharma A, Hanna DB, Anastos K, Kaplan RC, Levsky JM, Tien PC, Radparvar AA, Bortnick AE, Budoff[...]

Urine-guided Hydration and Kidney Injury: Comment

Delaporte A, Maghen B, Grogan T, Legrand M, Joosten A. Urine-guided Hydration and Kidney Injury: Comment. Anesthesiology. 2026 Apr 9. doi: 10.1097/ALN.0000000000006003. Epub ahead of[...]

Mechanisms of resistance to Tmprss6 antisense oligonucleotides in a mouse model of β-thalassemia

Zhang V, Barrett TD, Nemeth E, Ganz T. Mechanisms of resistance to Tmprss6 antisense oligonucleotides in a mouse model of β-thalassemia. Blood. 2026 Apr 9:blood.2026033274.[...]